This Analyst Boosts PT On PepsiCo? Plus UBS Sees $75 For Micron Technology
Deutsche Bank raised the price target on PepsiCo, Inc. (NASDAQ: PEP) from $179 to $181. Deutsche Bank analyst Steve Powers maintained a Hold rating on the stock. PepsiCo shares fell 1.2% to $166.47 on Tuesday.
HC Wainwright & Co. Maintains Buy on Equillium, Raises Price Target to $20
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Equillium (NASDAQ:EQ) with a Buy and raises the price target from $15 to $20.
Equillium Announces Interim Results From EQUALISE Study In With Lupus Nephritis; Says ‘5 of 6 (83%) subjects achieved complete or partial response and 4 of 6 (67%) subjects achieved > 80% reduction in urine protein creatinine ratio (UPCR) by week 28’
Itolizumab demonstrates clinically meaningful response in highly proteinuric subjects:
5 of 6 (83%) subjects achieved complete or partial response and 4 of 6 (67%) subjects achieved > 80% reduction
SVB Leerink Maintains Outperform on Equillium, Lowers Price Target to $12
SVB Leerink analyst Thomas Smith maintains Equillium (NASDAQ:EQ) with a Outperform and lowers the price target from $14 to $12.
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
Equillium Inc (NASDAQ:EQ) has agreed to acquire Metacrine Inc (NASDAQ:MTCR) in an all-stock transaction. The transaction is anticipated to add $33 million…
Equillium Q2 EPS $(0.41) Down From $(0.31) YoY
Equillium (NASDAQ:EQ) reported quarterly losses of $(0.41) per share. This is a 32.26 percent decrease over losses of $(0.31) per share from the same period last year.
